Skip to main content
Article thumbnail
Location of Repository

Construction and analysis of a modular model of caspase activation in apoptosis

By Heather A Harrington, Kenneth L Ho, Samik Ghosh and KC Tung
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2672941
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1996). A and Earnshaw W: ICE-related proteases in apoptosis. Curr Opin Genet Dev
    2. (2000). A mathematical model of caspase function in apoptosis. Nat Biotechnol
    3. (2004). A Mathematical Model of Receptor – Mediated Apoptosis: Dying to Know Why FASL Is a Trimer. Math Biosci Eng
    4. (1995). a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis. Cell
    5. (1993). A novel domain within the 55 kd TNF receptor signals cell death. Cell
    6. (2004). A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science
    7. (2002). Alnemri ES and Hajnoczky G: Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization.
    8. Am a t h e m a t i c a lm o d e lf o r apoptosome assembly: the optimal cytochrome c/Apaf-1 ratio. JT h e o rB i o l2006,
    9. (1998). An induced proximity model for caspase-8 activation.
    10. (2000). Apaf-1 oligomerizes into biologically active ~700-kDa and inactive ~1.4-MDa apoptosome complexes. JB i o l Chem
    11. Apaf-1/cytochrome c-independent and Smacdependent induction of apoptosis in multiple myeloma (MM) cells.
    12. (1997). Apoptosis by death factor. Cell
    13. (1999). Apoptosis in human disease: a new skin for the old ceremony?. Biochem Biophys Res Commun
    14. (1995). Apoptosis in the pathogenesis and treatment of disease. Science
    15. (1999). Apoptosis: Dead end for neurodegeneration?. Nature
    16. (1991). Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol
    17. (2000). Apoptotic pathways: paper wraps stone blunts scissors. Cell
    18. (1998). Ashkenazi A and Dixit V: Death receptors: signaling and modulation. Science
    19. (2000). Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria.
    20. (1995). Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis.
    21. (2008). Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is Theoretical Biology and Medical Modelling
    22. (2000). Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol
    23. (1999). Biochemical pathways of caspase activation during apoptosis. Ann Rev Cell Dev Biol
    24. Bistability analyses of a caspase activation model for receptor-induced apoptosis. JB i o lC h e m2004,
    25. (2006). Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores.
    26. (1999). Caspase activation involes the formation of the apoptsome, a large (~700 kDa) caspase-activating complex.
    27. (1999). Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev
    28. (1998). Caspases: enemies within. Science
    29. (1998). Caspases: the proteases of the apoptotic pathway. Oncogene
    30. (2004). Cell Death Critical Control Points. Cell
    31. (1998). Cell suicide for beginners.
    32. (2001). Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene
    33. (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell
    34. (2003). Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol
    35. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell
    36. (2000). Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. JB i o l Chem
    37. (2004). Cytochrome c-mediated apoptosis. Ann Rev Biochem
    38. (2000). Death by numbers.
    39. (2004). Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis. JC e l lB i o l
    40. (2001). Differential Expression of Apoptotic ProteaseActivating Factor-1 and Caspase-3 Genes and Susceptibility to Apoptosis during Brain Development and after Traumatic Brain Injury.
    41. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.
    42. (2005). Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions.
    43. (2003). Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway. Exp Cell Res
    44. (2000). Finch A and Evan G: Apoptosis in development.
    45. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) deathinducing signaling complex. Cell
    46. Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on
    47. (2001). Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol
    48. (1999). From molecular to modular cell biology. Nature
    49. (2000). Huang Z and Alnemri ES: Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway.
    50. (2006). Integrated mechanistic and data-driven modelling for multivariate analysis of signalling pathways.
    51. (2005). Integrative model of the response of yeast to osmotic shock. Nat Biotechnol
    52. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell
    53. (2008). Lauffenburger DA and Sorger PK: Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol Cell
    54. (2006). Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS Comput Biol
    55. (2005). Mathematical modeling of the regulation of caspase-3 activation and degradation. JT h e o r Biol
    56. (2008). Models and computational strategies linking physiological response to molecular networks from largescale data. Philos Transact A Math Phys Eng Sci
    57. (2005). Modular Interdependency in Complex Dynamical Systems. Artificial Life
    58. (2001). Programmed cell death and apoptosis: origins of the theory. Nat Rev Mol Cell Biol
    59. (1997). Programmed cell death in animal development. Cell
    60. (2002). Programmed cell death in the developing limb.
    61. (2000). Proteases for cell suicide: Functions and regulation of caspases. Microbiol Mol Biol Rev
    62. (1981). Receptor clustering on a cell surface. III. Theory of receptor cross-linking by multivalent ligands: description by ligand states.
    63. (2002). Ruefli AA and Lowe SW: Apoptosis: a link between cancer genetics and chemotherapy. Cell
    64. (1998). Salvesen GS and Reed JC: IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases.
    65. (1995). Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. JB i o l Chem
    66. Simple computational models of type I/type II cells in Fas signaling-induced apoptosis. JT h e o rB i o l2008,
    67. (2000). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell
    68. (1984). Some mathematical models of receptor clustering by multivalent ligands. Cell Surface Dynamics: Concepts and Models Marcel Dekker: Delisi C, Wiegel F, Perelson A
    69. (2004). Stress-induced apoptosis: Toward a symmetry with receptor-mediated cell death. Apoptosis
    70. (2002). The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie
    71. (2006). The Bax pore in liposomes, Biophysics. Cell Death Differ
    72. (1998). The Bcl-2 protein family: arbiters of cell survival. Science
    73. (2000). The biochemistry of apoptosis. Nature
    74. (1980). The biophysics of ligand-receptor interactions.
    75. (2004). The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta
    76. (2001). The machinery of programmed cell death. Pharmacol Ther
    77. (1994). The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell
    78. (1998). The two CD95 apoptosis signaling pathways may be a way of cells to respond to different amounts and/or forms of CD95 ligand produced in different tissues.
    79. TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid and Bax but differentially regulate events downstream from truncated Bid. JB i o lC h e m2002,
    80. (1995). Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood
    81. (2008). Two independent positive feedbacks and bistability in the Bcl-2 apoptotic switch. PLoS ONE
    82. (1994). Why does stage 4s neuroblastoma regress spontaneously?. Lancet
    83. (1998). Why neurons die: cell death in the nervous system. Anat Rec
    84. (2003). y p eI / T y p eI I model. Semin Immunol
    85. (2000). Youle RJ and Tjandra N: Structure of Bax: coregulation of dimer formation and intracellular localization. Cell

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.